First Republic Investment Management, Inc. Bright Minds Biosciences Inc. Transaction History

First Republic Investment Management, Inc.

  • $34.7 Billion
  • Q3 2023

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
BUY
$0.75 - $6.5 $8,496 - $73,638
11,329 New
11,329 $14,000

About BRIGHT MINDS BIOSCIENCES INC.

DRUG Quotes by TradingView
  • Ticker DRUG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,209,900
  • Market Cap $640M
  • Description
  • Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collabor...
More about DRUG
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email